TY - JOUR
T1 - Psychological and pharmacological interventions for social anxiety disorder in adults
T2 - A systematic review and network meta-analysis
AU - Mayo-Wilson, Evan
AU - Dias, Sofia
AU - Mavranezouli, Ifigeneia
AU - Kew, Kayleigh
AU - Clark, David M.
AU - Ades, A. E.
AU - Pilling, Stephen
N1 - Funding Information:
EM-W, IM, KK, and SP received support from NICE. SD and AEA received support from the Centre for Clinical Practice (NICE), with funding from the NICE Clinical Guidelines Technical Support Unit, University of Bristol. DMC is a National Institute for Health Research Senior Investigator and is supported by the Wellcome Trust ( 069777 ). We thank Sarah Stockton, who developed the electronic search strategy with input from the authors. We thank the Guideline Development Group for the NICE guideline Social anxiety disorder: recognition, assessment and treatment (Safi Afghan, Peter Armstrong, Madeleine Bennett, Sam Cartwright-Hatton, Cathy Creswell, Melanie Dix, Nick Hanlon, Andrea Malizia, Jane Roberts, Gareth Stephens, and Lusia Stopa). We received support from colleagues at the NCCMH, including Benedict Anigbogu, Nuala Ernest, Katherine Leggett, Kate Satrettin, Melinda Smith, Clare Taylor, and Craig Whittington. Several colleagues also provided helpful feedback, including Andrea Cipriani, Richard Heimberg, Ron Rapee, and Franklin Schneier.
Publisher Copyright:
© 2014 Mayo-Wilson et al. Open Access article distributed under the terms of CC BY.
PY - 2014/10/1
Y1 - 2014/10/1
N2 - Background: Social anxiety disorder-a chronic and naturally unremitting disease that causes substantial impairment-can be treated with pharmacological, psychological, and self-help interventions. We aimed to compare these interventions and to identify which are most effective for the acute treatment of social anxiety disorder in adults. Methods: We did a systematic review and network meta-analysis of interventions for adults with social anxiety disorder, identified from published and unpublished sources between 1988 and Sept 13, 2013. We analysed interventions by class and individually. Outcomes were validated measures of social anxiety, reported as standardised mean differences (SMDs) compared with a waitlist reference. This study is registered with PROSPERO, number CRD42012003146. Findings: We included 101 trials (13 164 participants) of 41 interventions or control conditions (17 classes) in the analyses. Classes of pharmacological interventions that had greater effects on outcomes compared with waitlist were monoamine oxidase inhibitors (SMD -1·01, 95% credible interval [CrI] -1·56 to -0·45), benzodiazepines (-0·96, -1·56 to -0·36), selective serotonin-reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors (SSRIs and SNRIs; -0·91, -1·23 to -0·60), and anticonvulsants (-0·81, -1·36 to -0·28). Compared with waitlist, efficacious classes of psychological interventions were individual cognitive-behavioural therapy (CBT; SMD -1·19, 95% CrI -1·56 to -0·81), group CBT (-0·92, -1·33 to -0·51), exposure and social skills (-0·86, -1·42 to -0·29), self-help with support (-0·86, -1·36 to -0·36), self-help without support (-0·75, -1·25 to -0·26), and psychodynamic psychotherapy (-0·62, -0·93 to -0·31). Individual CBT compared with psychological placebo (SMD -0·56, 95% CrI -1·00 to -0·11), and SSRIs and SNRIs compared with pill placebo (-0·44, -0·67 to -0·22) were the only classes of interventions that had greater effects on outcomes than appropriate placebo. Individual CBT also had a greater effect than psychodynamic psychotherapy (SMD -0·56, 95% CrI -1·03 to -0·11) and interpersonal psychotherapy, mindfulness, and supportive therapy (-0·82, -1·41 to -0·24). Interpretation: Individual CBT (which other studies have shown to have a lower risk of side-effects than pharmacotherapy) is associated with large effect sizes. Thus, it should be regarded as the best intervention for the initial treatment of social anxiety disorder. For individuals who decline psychological intervention, SSRIs show the most consistent evidence of benefit. Funding: National Institute for Health and Care Excellence.
AB - Background: Social anxiety disorder-a chronic and naturally unremitting disease that causes substantial impairment-can be treated with pharmacological, psychological, and self-help interventions. We aimed to compare these interventions and to identify which are most effective for the acute treatment of social anxiety disorder in adults. Methods: We did a systematic review and network meta-analysis of interventions for adults with social anxiety disorder, identified from published and unpublished sources between 1988 and Sept 13, 2013. We analysed interventions by class and individually. Outcomes were validated measures of social anxiety, reported as standardised mean differences (SMDs) compared with a waitlist reference. This study is registered with PROSPERO, number CRD42012003146. Findings: We included 101 trials (13 164 participants) of 41 interventions or control conditions (17 classes) in the analyses. Classes of pharmacological interventions that had greater effects on outcomes compared with waitlist were monoamine oxidase inhibitors (SMD -1·01, 95% credible interval [CrI] -1·56 to -0·45), benzodiazepines (-0·96, -1·56 to -0·36), selective serotonin-reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors (SSRIs and SNRIs; -0·91, -1·23 to -0·60), and anticonvulsants (-0·81, -1·36 to -0·28). Compared with waitlist, efficacious classes of psychological interventions were individual cognitive-behavioural therapy (CBT; SMD -1·19, 95% CrI -1·56 to -0·81), group CBT (-0·92, -1·33 to -0·51), exposure and social skills (-0·86, -1·42 to -0·29), self-help with support (-0·86, -1·36 to -0·36), self-help without support (-0·75, -1·25 to -0·26), and psychodynamic psychotherapy (-0·62, -0·93 to -0·31). Individual CBT compared with psychological placebo (SMD -0·56, 95% CrI -1·00 to -0·11), and SSRIs and SNRIs compared with pill placebo (-0·44, -0·67 to -0·22) were the only classes of interventions that had greater effects on outcomes than appropriate placebo. Individual CBT also had a greater effect than psychodynamic psychotherapy (SMD -0·56, 95% CrI -1·03 to -0·11) and interpersonal psychotherapy, mindfulness, and supportive therapy (-0·82, -1·41 to -0·24). Interpretation: Individual CBT (which other studies have shown to have a lower risk of side-effects than pharmacotherapy) is associated with large effect sizes. Thus, it should be regarded as the best intervention for the initial treatment of social anxiety disorder. For individuals who decline psychological intervention, SSRIs show the most consistent evidence of benefit. Funding: National Institute for Health and Care Excellence.
UR - http://www.scopus.com/inward/record.url?scp=84920033238&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84920033238&partnerID=8YFLogxK
U2 - 10.1016/S2215-0366(14)70329-3
DO - 10.1016/S2215-0366(14)70329-3
M3 - Article
AN - SCOPUS:84920033238
SN - 2215-0366
VL - 1
SP - 368
EP - 376
JO - The Lancet Psychiatry
JF - The Lancet Psychiatry
IS - 5
ER -